Overview

A Trial Comparing S1 Generic With Capecitabine in Metastatic Breast Cancer (MBC)

Status:
Terminated
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
Comparing S1 generic With Capecitabine in Patients With Metastatic Breast Cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Fudan University
Treatments:
Capecitabine
Tegafur